Results 61 to 70 of about 12,998,017 (261)

Impact of hospital diagnosis-specific quality measures on patients’ experience of hospital care: Evidence from 14 states, 2009-2011 [PDF]

, 2016
In order to assess consistency across quality measures for Untied States hospitals, this paper uses patient responses to the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey for three years (2009-2011) from 1,333 acute ...
Kenton J Johnston, Jason Hockenberry, Hockenberry, Jason M., Jaeyong Bae, Becker, Edmund, Emily M Johnston, Johnston, Kenton J, Emily Johnston, Arnold Milstein, Kenton Johnston, Johnston, Emily M, Jason M. Hockenberry, Bae, Jaeyong, Edmund Becker, Milstein, Arnold   +14 more
core   +1 more source

Understanding patient and caregiver perspectives using a dyad approach for data collection: A systematic review of the literature [PDF]

, 2022
Treatments outside of a clinical setting may be managed independently by the pediatric patient, independently by a caregiver, or by the patient and caregiver together.
Andrew Yaworsky, Love, Emily, Andrew Palladino, Lamoureux, Roger, Palladino, Andrew, Emily Love, Roger Lamoureux, Loftus, Jane, Jane Loftus, Andreas M. Pleil, Yaworsky, Andrew, Turner-Bowker, Diane M., Pleil, Andreas M., Diane M. Turner-Bowker   +13 more
core   +1 more source

Exploring Patient‐Reported Outcome Measures and Patient‐Reported Experience Measures in Cardiovascular Value‐Based Healthcare

Nursing & Health Sciences
ABSTRACT The use of Patient‐Reported Outcome Measures (PROMs) and Patient‐Reported Experience Measures (PREMs) in cardiovascular disease (CVD) healthcare is an area of global growing interest for improving patient clinical outcomes.
Soon Yeng Soo Hoo, Kathryn Kynoch
openaire   +2 more sources

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

The patient patient: The importance of knowing your navigator [PDF]

, 2015
In Ontario, Diagnostic Assessment Programs (DAPs) have been implemented to improve the quality of care patients receive during the diagnostic phase of the cancer journey.
Kaan, Melissa, MBA, Holloway, Claire MB, MD PhD FRCSC, Gilbert, Julie E, PhD, Klonikowski, Eric, Wheeler, Sarah M, PhD   +4 more
core   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

PROMs and PREMs in routine perinatal care: mixed methods evaluation of their implementation into integrated obstetric care networks

Journal of Patient-Reported Outcomes, 2023
Background In the transition towards value-based healthcare, patient-reported outcome and experience measures (PROM and PREM) are recommended by international collaborations and government programs to guide clinical practice and quality improvement.
Anne L. Depla, Bettine Pluut, Marije Lamain-de Ruiter, Anna W. Kersten, Inge M. Evers, Arie Franx, Mireille N. Bekker   +6 more
doaj   +1 more source

Development and Validation of the Diabetes Pen Experience Measure: A New Patient-Reported Outcome Measure

Journal of Diabetes Science and Technology, 2022
Background: Satisfaction with insulin-delivery devices has been shown to improve treatment adherence, translating into better glycemic control. The Diabetes Pen Experience Measure (DPEM) is a new patient-reported outcome measure to evaluate patients’ experience when using an injection device.
Meryl Brod, Laura Tesler Waldman, Thomas Sparre, Anne Kirstine Busk   +3 more
openaire   +2 more sources

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari, Regina Hadi Putri, Fatimah Assyifa, Judith Spijkerman, Gertjan Johannes Kaspers, Susi Susanah   +5 more
wiley   +1 more source